Vancouver’s Redwood AI has been named a finalist for the Company of the Year – Startup award at the 2025 BC Tech TIAs. The company is tackling global drug shortages by modernizing outdated chemistry workflows with proprietary AI models built from scratch. Redwood’s platform generates multiple synthetic pathways for drug molecules while factoring in cost, safety, and supply chain realities.
CEO Louis Dron credits BC’s growing biotech and AI ecosystem for Redwood’s momentum, which includes improved model accuracy and a soon-to-close funding round. The recognition underscores Redwood’s mission to bring automation and intelligence to pharmaceutical manufacturing.
Want to know more? Check out the source code on Techcouver.